Aesthetic medicine mkt to triple by 2029, driven by non-surgical procedures
I ndia is emerging as a global powerhouse in the aesthetic medicine market, with a projected threefold increase in value to $3.02 billion by 2029. This rapid growth is driven by a rising preference for non-invasive procedures like Botox and fillers, coupled with increasing disposable incomes and a growing health-conscious population. The International Society of Aesthetic Plastic Surgery reported a significant shift towards non-surgical procedures, which outnumbered surgical ones globally in 2020. Botulinum toxin remains the most popular non-surgical procedure, with over 9 million treatments performed by plastic surgeons worldwide, marking a 26.1 per cent increase. Click here to connect with us on WhatsApp Hyaluronic acid procedures followed with 4.3 million treatments. Women dominate the market, comprising 85.7 per cent of the consumer base, but there is a growing acceptance of aesthetic treatments among men and millennials, reshaping the industry’s demographics. India’s current aes